You searched for "outcome"

1824 results found

Assessing extended high-frequency hearing

The frequency range of human hearing spans 20 Hz to 20 kHz. In the UK, standard audiometry usually assesses 0.25–8 kHz; the extended high frequencies (EHFs) are those above 8 kHz. The importance of assessing EHF hearing has been increasingly...

Office-based PRP injection for benign vocal fold disorders

Awake transnasal laryngeal injection has become globally popularised. This article discusses autologous plasma as a regenerative alternative to synthetic materials. Regenerative therapies are increasingly being explored across a range of specialties. Among these, platelet-rich plasma (PRP) has seen the widest...

Can we prevent chronic rhinosinusitis?

The old adage ‘prevention is better than cure’ is considered by Professor Hopkins in respect to chronic rhinosinusitis, a condition affecting around 10% of the adult population and associated with huge impact on quality of life and economic cost. A...

Swallowing outcomes following partial laryngectomy: objective assessment and pre-operative predictive factors

Partial laryngectomy constitutes one of the treatments for early stage glottic carcinoma (i.e. T1N0 and T2N0) in specialised centres. Over the years, several partial laryngectomy and reconstruction techniques have been described in the literature. The choice of technique depends on...

Outcomes of larger glottic cancer volumes treated with radiotherapy

T3 glottic cancer is characterised as vocal cord fixation and/or invasion into pre-epiglottic, post-cricoid, paraglottic spaces and/or within the inner cortex of thyroid cartilage. Traditionally, laryngectomy was considered the primary option to treat T3 laryngeal glottic cancers until other options...

Does salvage treatment in sudden sensorineural hearing loss work?

Many treatment strategies for sudden sensorineural hearing loss (SSNHL) have been discussed, but the high spontaneous recovery rate (32-65%) of idiopathic SSNHL and differing treatment guidelines make comparing outcomes difficult. Systemic steroids are the most common first-line therapy with significant...

Extranodal extension following surgical resection of HPV-positive oropharyngeal cancer – is adjuvant radiotherapy alone sufficient?

Human papillomavirus (HPV) is a known aetiological factor in oropharyngeal squamous cell carcinoma (OPSCC). HPV-positive OPSCC is recognised to have a more favourable prognosis than HPV-negative disease. Treatment deintensification for HPV+ OPSCC has therefore been an area of research focus...

Bevacizumab, NF2, hearing and age

Introduction NF2-related schwannomatosis (NF2-SWN) is an autosomal dominant disorder leading to the development of schwannomas, meningiomas and spinal cord ependymomas. Younger age is a negative prognostic factor. Treatment includes observation, surgery, radiotherapy and medical therapy with bevacizumab (VEGF monoclonal antibody)....

Hope for neural hearing loss

A new review shows significant promise of improved clinical outcomes for patients from the treatments in development for neural hearing loss (NHL), alongside better diagnosis.

Internet-based cognitive behavioural therapy for adults with tinnitus

Tinnitus remains one of the most prevalent and distressing audiological symptoms. Although specialist tinnitus services are in high demand, geographical and service constraints result in limited access to these services. Internet-based cognitive behavioural therapy (ICBT) has been developed to provide...

Oral Tissue Collaborative Symposium

Building Excellence in Oral Tissue Biobanking

Early habilitation for hearing impairment in children with Down syndrome

Approximately 40-80% of children with Down syndrome have hearing impairment in addition to speech and language impairment. The commonest cause of hearing impairment in young children is otitis media with effusion. This paper investigated the impact of early hearing loss...